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I. Abstract
Cell transfection is an exemplary tool in protein analysis and examining transcription factor activity.
While general procedures are commonly followed, each cell line requires slight differentiation in
pBABE/PEI JET ratios and initial cell count for optimal transfection results. This research focusses
on determining a successful procedure for TOV-112 carcinoma cells for future work with
2-methoxyestradiol and NFkB. 2-methoxyestradiol is an angiogenesis inhibitor believed to
decrease inflammatory processes. NFkB promoter controls the luciferase gene on the MetLuc
plasmid and is pro-inflammatory. The objective of this experiment is to modify the variables until
successful results at 24 and 48 hours are observed. Four experimental transfections were conducted
during the three months of research, which analyzed the effectiveness of high and low
pBABE/PEI JET ratios and increased vs. decreased initial plate seeding. Results show that optimal
TOV-112 transfection occurs with a 1:2 pBABE/PEI JET ratio and an initial cell count of around
3x10^5 cells/mg. Future work will hope to emphasize this conclusion and continue with the
overarching NFkB ovarian cancer research, which aims to reduce the cases of lethal occurrences.
II. Introduction
Cell transfection, the introduction of foreign nucleic acids on eukaryotic cells for the purpose of
genetic uptake and experimental observance, is a useful experimental tool to measure activity of
various proteins and transcription factors, [6]. While similar in technique, diversified kinds of cells
require slight manipulations in the overall procedure. TOV-112 are human endometrial histotype
carcinoma cells known to cause ovarian cancer, [8]. This form of cancer has an excessively high
mortality rate due to late-stage diagnostic findings. With no modern mechanisms for early
diagnosis, ovarian carcinoma female lethality is fifth in cancer deaths, [2, 4-5]. In successful
ovarian cancer transfections, there are great potentials in advancement for ovarian cancer studies
and with deeper information, earler detection may be possible. In this form of cell transfection,
TOV-112 cells are grown in 90% Dulbecco's Modified Eagle Medium, 10% Fetal Bovine Serum,
and 0.5% Penicillin streptomycin. DMEM is rich in glucose and other growth nutrients, which
allow for optimal and healthy cell growth, [3]. TOV-112 cells double in about a period of 22 hours,
which requires greater upkeep and nutrient availability. FBS and Penstrep also ensure proper
growth where FBS has increased growth serum and Penstrep is antibacterial. Penstrep is later
removed from the growth medium to establish limited barriers for genetic uptake. The ovarian
cancer cells are transfected with pBABE plasmid. This carries the gene for the Green Fluorescent
Protein (GFP). When the plasmid is translated, transfected cells can be visualized by fluorescent
microscopy, [7]. Image 1.0 below shows the pBABE plasmid map that contains the genetic
material for GFP translation. Ampicillin-resistant genetic material with the pBABE plasmid was
amplified via Polymerase Chain Reaction (PCR) and the pBABE plasmid was extracted and
isolated. Since transfection, in most cases, would be lethal to the delicate cells, Opti-MEM media
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buffers the solution with HEPES and Sodium Bicarbonate, [3]. PEI-JET is used for efficient gene
delivery. The purpose of this research is to find an optimal transfection procedure for TOV-112
cells by varying the pBABE and PEI JET ratios and manipulating the original cell count at the
beginning of the transfection. This determination leads into future research with Metridia
Luciferase (MetLuc) transfection and 2-methoxyestradiol introduction to see if there is a decrease
in luciferase protein activation proportional to Nuclear Factor kappa Beta (NFkB) activity. MetLuc
is a plasmid that contains the genetic coding for luciferase. The MetLuc gene is controlled by the
NFkB promoter. NFkB is a transcription factor that promotes angiogenesis in the presence of
ovarian cancer. It participates in inflammatory processes and since ovulation is pro-inflammatory, it
is believed to be involved with ovarian cancer cases. Determining if 2-methoxyestradiol attracts
anti-inflammatory processes in-vitro could later be conducted in-vivo as a means to reduce the
virulence of the carcinoma. Previous studies show that 2-methoxyestradiol induces tumor apoptosis
and has anti-inflammatory properties, [1].
Image 1.0: pBABE Plasmid Map (Snapgene)
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III. Materials and Methods
Transfection 1: pBABE-PEI JET Variations with Low Ratios
I thawed a vile of TOV-112 ovarian cancer cells frozen from 04/2017 with a passage number of 36
on a 100-mL cell culture plate and grew/transferred the cells until five passages have passed. Each
cell culture plate had 12-mL of 90%DMEM, 10%FBS, and 0.5% Penstrep media. In each passage,
cells grew for 48-72 hours (until 100% confluence). Passage 41 TOV-112 cells were transferred to
a 6-well plate with a cell count of 7.0x10^5 cells/mg and 2-mL of 90% DMEM, 10%FBS, and
0.5% Penstrep media in each well. In five-1mL conical tubes, I mixed 200-μL Optimem Media;
1.0-μg, 1.25-μg, 1.5-μg, 1.75-μg, and 2-μg pBABE (0.47μg/μL concentration) respectively, and
6.0μg of vortexed PEI-JET (1.0μg/μL concentration). Each 1-mL conical tube was vortexed every
five minutes for fifteen minutes at T 0min, 5min, 10min, and 15min. The 90% DMEM, 10% FBS,
and 0.5% Penstrep media was replaced with 90%DMEM and 10% FBS media in each well
(2-mL). The pBABE mixtures were added to wells 1-5 respectively, leaving well 6 as the control.
The cells grew for 48 total hours with observations under a compound microscope to see the
fluorescence at T-24hours and T-48hours.
Transfection 2: Initial Cell Count Variations
I transferred the 100-mL cell culture plate of P43 TOV-112 cells from my maintained cell line to a
6-well cell culture plate. Initial cell counts were 6.0x10^5, 6.5x10^5, 7.0x10^5, 7.5x10^5, and
8.0x10^5 cells/mg respectively in wells 1-5. The control in well 6 was plated with 7.0x10^5-the
average of all experimental values. Each well had 2-mL of 90%DMEM, 10%FBS, and
0.5%Penstrep media. In five 1-mL conical tubes, I mixed 200-μL Optimem Media, 2-μg pBABE
(concentration 0.47 μg/μL), and 6-μg of vortexed PEI-JET (1.0 μg/μL concentration). Each 1-mL
conical tube was vortexed every five minutes for fifteen minutes at T 0min, 5min, 10min, and
15min. The 90% DMEM, 10% FBS, and 0.5%Penstrep media was replaced with 90%DMEM and
10% FBS media in each well (2-mL). The pBABE mixtures were added to wells 1-5 respectively,
leaving well 6 as the control. The cells grew for 48 total hours with observations under a
compound microscope to see the fluorescence at T-24hours and T-48hours.
Transfection 3: Initial Cell Count Variation
I transferred the 100-mL cell culture plate with P47 TOV-112 cells from my maintained cell line to
a 6-well cell culture plate. Initial cell counts were 6.5x10^3 (in wells 1 and 4), 6.5x10^4 (wells 2
and 5), and 6.5x10^5 (wells 3 and 6) cells/mg. Wells 4, 5 and 6 were used as controls. Each well
had 2-mL of 90%DMEM, 10%FBS, and 0.5%Penstrep media. In three 1-mL conical tubes, I
mixed 200-μL Optimem Media, 2-μg pBABE (concentration 0.811 μg/μL), and 6-μg of vortexed
PEI-JET (1.0 μg/μL concentration). Each 1-mL conical tube was vortexed every five minutes for
fifteen minutes at T 0min, 5min, 10min, and 15min. The 90% DMEM, 10% FBS, and
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0.5%Penstrep media was replaced with 90%DMEM and 10% FBS media in each well (2-mL).
The pBABE mixtures were added to wells 1-3, respectively, leaving well 4, 5, and 6 as the
controls. The cells grew for 48 total hours with observations under a compound microscope to see
the fluorescence at T-24hours and T-48hours.
Transfection 4: pBABE-PEI JET Variations
The passage 51 TOV-112 cells were transferred to a 6-well plate with a cell count of 3.0x10^5
cells/mg and 2-mL of 90% DMEM, 10%FBS, and 0.5%Penstrep media in each well. In three-1mL
conical tubes, I mixed 200-μL Optimem Media; 3.0-μg, 2.0-μg, 1.0-μg pBABE (0.811 μg/μL
concentration), respectively, and 6.0μg of vortexed PEI-JET (1.0μg/μL concentration). Each 1-mL
conical tube was vortexed every five minutes for fifteen minutes at T 0min, 5min, 10min, and
15min. The 90% DMEM, 10% FBS, and 0.5%Penstrep media was replaced with 90%DMEM and
10% FBS media in each well (2-mL). The pBABE mixtures were added to wells 1-3 respectively,
leaving wells 4, 5, and 6 as the controls. The cells grew for 48 total hours with observations under
a compound microscope to see the fluorescence at T-24hours and T-48hours.

IV. Results
Transfection 1: pBABE/PEI JET Ratio Variations
Results show an increase number of pBABE transfected TOV-112 cells with lower pBABE/PEI
JET ratios. There is also increased expansion with the fluorescent cells and limited patched
transfection areas that are prevalent with the lower concentration ratios. Transfected cells are
indicated by the bright green areas in the first column. The second column shows the brightfield
image at that time.

Figure 1.1: Results at 24 Hours
1:6

1.25:6

1:4

1.75:6

1:3
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Figure 1.2: Results at 48 Hours
1:6

1.25:6

1:4

1.75:6

1:3

Transfection 2: Initial Cell Count Variations
There is an increase in positive transfected cells with the initial cell count of 6.5x10^5 cells/μg.
Though it shows the most success, there is still a very limited number of positive transfections in
each well. Transfected cells are indicated by the bright green areas in the first column. The second
column shows the brightfield image at that time.

Figure 2.1: Results at 24 Hours
6.0x10^5

6.5x10^5

7.0x10^5

7.5x10^5

8.0x10^5
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Figure 2.2: Results at 48 Hours
6.0x10^5

6.5x10^5

7.0x10^5

7.5x10^5

8.0x10^5

Transfection 3: Initial Cell Count Variations
The Results below show wells seeded with low initial cell counts. This was in attempt to combat
the excessive confluency and cell death from the previous transfections. There is a very limited
number of successful transfected cells and little variation between the three experimental wells. I
used “6.5” since it previously showed a greater number of transfected cells in Transfection 2.
Transfected cells are indicated by the bright green areas in the first column. The second column
shows the brightfield image at that time.

Figure 3.1: Results at 24 Hours
6.5x10^3

6.5x10^4

6.5x10^5
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Figure 3.2: Results at 48 Hours
6.5x10^3

6.5x10^4

6.5x10^5

Transfection 4: pBABE/PEI JET Variation with Low Ratios
The final transfection, again, varied the ratio of pBABE and PEI JET in attempt to visualize
whether or not a lower ratio constitutes a greater successful output. I cut the previously successful
initial cell count to 3x10^5 in attempt to, again, counteract the initial cell death that occurs at high
levels of confluency. There were three experimental wells with 1:6, 1:3, and 1:2 pBABE/PEI JET
ratios respectively. Transfected cells are indicated by the bright green areas in the first column. The
second column shows the brightfield image at that time.

Figure 4.1: Results at 24 Hours
1:6

1:3

1:2
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Figure 4.2: Results at 48 Hours
1:6

1:3

1:2

V. Discussion
PEI-JET and pBABE ratios show a drastic difference in transfection efficiency since the Green
Fluorescent Protein utilizes PEI-JET for its genetic deliverance. Results show that lower ratios
promote successful transfections, indicated by the increased level of green fluorescence cells. Initial
cell count plays a secondary role in transfection success with the TOV-112 cells. In the comparison
of transfection 2 with transfection 3, though high levels of initial cell count resulted in a greater
incidence of cell death at the 48 hour mark, vastly decreasing the original plate seeding resulted in
confluence that was not optimal for success. With a low pBABE/PEI JET ratio and a slight
decrease in original seeding to 3x10^5 cells/mg (reaching 100% confluency by 24 hours), there
was an elevation in pBABE-transfected TOV-112 ovarian cancer cells. Thus, in responding to the
initial thesis question and in hopes to regulate the transfection procedure for this type of carcinoma
cell line, the results illustrate that success correlates with a low pBABE/PEI JET ratio and an initial
cell count around 3x10^5 cells/mg. A revised procedure that take these results into account is as
follows:
Grow TOV-112 ovarian cancer cells to 80% confluency on a 100-mL cell culture
plate in 12-mL of 90% DMEM, 10% FBS, and 0.5% Penstrep media. Seed a
6-well plate with an initial cell count of 3x10^5 cells/mg. Add 2-mL of the 90%
DMEM, 10% FBS, and 0.5% Penstrep media to each well. Incubate the cells for 24
hours. At this mark, add 200-μL of Optimem media, 6-μg vortexed PEI-JET, and
3-μg of pBABE in a 1.5-mL conical tube. Repeat this for each experimental well.
Vortex each tube for 10-seconds at T-0min, 5min, 10min, and 15min. Carefully
replace the present media in the 6-well plate with 2-mL of 90% DMEM and 10%
FBS in each well. Add the conical tube mixtures to their respective wells. Carefully
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move the plate to swirl the mixture and incubate. Observe the cells at 24 and 48
hours.
While the experiments were successful in formulating a more accurate transfection procedure for
TOV-112 cells, more transfection repeats could have been conducted for better result accuracy.
Future work will focus on this repetition and utilize the detailed transfection procedure. Possible
errors in experimentation may include working with two different concentrations of pBABE and
therefore having a lack of control. Despite the different concentrations, however, calculations
accounted for the variation. With this resulting information, there may be future experiments
working with pBABE/MetLuc transfections with the introduction of 2-methoxyestradiol. MetLuc
is an plasmid that contains the luciferase gene. This gene is under control by the NFkB promoter.
NFkB is a transcription factor that is stimulated in response to cellular stress. Increased activity is
correlated with increased inflammatory response. Ovulation, essentially, is an inflammatory
process. If 2-methoxy attracts anti-inflammatory factors, the ovarian cancer over-inflammation
stimulated by NFkB, may be reduced. 2-methoxyestradiol is a natural metabolite of estrogen. By
co-transfecting the TOV-112 cells with pBABE and MetLuc, we can measure transfection
efficiency. Using a Luciferase protein assay, the amount of NFkB activity on TOV-112 cells can be
studied, since NFkB response is proportional to Luciferase activity. Introducing 2-methoxyestradiol
to the cell plate allows for the analysis of its anti-inflammatory action on the ovarian cancer cells by
observing the difference of NFkB activity over time. In conclusion, this study is a necessary step
for larger ovarian cancer research and the regulation of this procedure will help to diminish
possible errors with further experimentation.
VI. Acknowledgments
I want to thank Dr. Buck Hales for his support in the completion of the project and allowing the
usage of his laboratory to conduct the experiments. Thank you to my colleague, Kara
Starkweather, for initially showing the general method on how to complete transfections and others
in Dr. Buck Hale’s lab who supported me throughout the semester.
VII. Calculations
Transfection 1
248 cells x ⅖ x 10,000 = 9.92x10^5cells/1mL x 7x10^5cells/1mL = 70.6μL cell suspension/well
2.0 μL pBABE x 0.47 μg/μL pBABE = 1.0 μg pBABE
2.5 μL pBABE x 0.47 μg/μL pBABE = 1.25 μg pBABE
3.0 μL pBABE x 0.47 μg/μL pBABE = 1.5 μg pBABE
3.5 μL pBABE x 0.47 μg/μL pBABE = 1.75 μg pBABE
4.0 μL pBABE x 0.47 μg/μL pBABE = 2.0 μg pBABE
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Transfection 2
576 cells x ⅖ x 10,000 = 2.3 x 10^6 cells/mL
2.3x10^6 cells/mL = 6.0x10^5 = 0.261 mL cell suspension/well
2.3x10^6 cells/mL = 6.5x10^5 = 0.283 mL cells suspension/well
2.3x10^6 cells/mL = 7.0x10^5 = 0.304 mL cell suspension/well
2.3x10^6 cells/mL = 7.5x10^5 = 0.326 mL cell suspension/well
2.3x10^6 cells/mL = 8.0x10^5 = 0.348 mL cell suspension/well
Transfection 3
357 cells x ⅖ 10,000 = 1.43x10^6 cells/mL
1.43x10^6 cells/mL = 6.5x10^3 = 4.5 μL cell suspension/well
1.43x10^6 cells/mL = 6.5x10^4 = 45 μL cell suspension/well
1.43x10^6 cells/mL = 6.5x10^5 = 450 μL cell suspension/well
0.811 μg/μL pBABE x “x” = 2.0 μg/μL = 2.5 μL pBABE
Transfection 4
304 cells x ⅖ x 10,000 = 1.22x10^6 cells/mL x 3x10^5 cells/mL = 0.247 mL cell suspension/well
0.811 μg/μL pBABE = 3 μg/X μL = 3.7 μL pBABE
0.811 μg/μL pBABE = 2 μg/X μL = 2.5 μL pBABE
0.811 μg/μL pBABE = 1 μg/X μL = 1.2 μL pBABE
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